Robert Wasserman
Stock Analyst at Benchmark Co.
(4.34)
# 1,317
Out of 5,020 analysts
231
Total ratings
46.8%
Success rate
11.7%
Average return
Main Sectors:
Stocks Rated by Robert Wasserman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TLV: KMDA Kamada Ltd. | Reiterated: Buy | ILA 4,610 | ILA 2,541 | +81.44% | 6 | Sep 18, 2026 | |
| BLFS BioLife Solutions | Downgraded: Hold | n/a | $36.78 | - | 11 | Aug 10, 2026 | |
| LGND Ligand Pharmaceuticals | Reiterated: Buy | $220 → $335 | $302.74 | +10.66% | 20 | Jul 16, 2026 | |
| RGEN Repligen | Upgraded: Buy | $185 | $177.23 | +4.38% | 11 | Jul 7, 2026 | |
| PRLB Proto Labs | Reiterated: Buy | $91 | $94.37 | -3.57% | 16 | Jul 6, 2026 | |
| TECH Bio-Techne | Downgraded: Hold | n/a | $72.40 | - | 18 | Jun 30, 2026 | |
| ITGR Integer Holdings | Upgraded: Buy | $140 → $95 | $126.42 | -24.85% | 18 | Feb 20, 2026 | |
| HALO Halozyme Therapeutics | Reiterated: Buy | $90 | $106.94 | -15.84% | 22 | Feb 19, 2026 | |
| CDXS Codexis | Reiterated: Hold | n/a | $1.36 | - | 16 | Nov 14, 2025 | |
| OABI OmniAb | Reiterated: Buy | $6 → $4 | $4.99 | -19.84% | 11 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $3.21 | +1,068.22% | 7 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $13.91 | n/a | 8 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $3.67 | n/a | 8 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $6.37 | n/a | 20 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.33 | n/a | 8 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 | $3.49 | n/a | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $652.51 | n/a | 7 | Oct 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $211.76 | n/a | 5 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.88 | n/a | 4 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $80 | $1.62 | n/a | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $2.07 | n/a | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.09 | n/a | 3 | Jan 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $0.45 | n/a | 1 | Jan 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $46 | $0.749 | n/a | 1 | Aug 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $2.4 | $2.04 | n/a | 2 | Jan 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5.25 | $0.8213 | n/a | 1 | Nov 7, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $8.33 | n/a | 1 | Mar 12, 2013 |
Kamada Ltd.
Sep 18, 2026
Reiterated: Buy
Price Target: ILA 4,610
Current: ILA 2,541
Upside: +81.44%
BioLife Solutions
Aug 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $36.78
Upside: -
Ligand Pharmaceuticals
Jul 16, 2026
Reiterated: Buy
Price Target: $220 → $335
Current: $302.74
Upside: +10.66%
Repligen
Jul 7, 2026
Upgraded: Buy
Price Target: $185
Current: $177.23
Upside: +4.38%
Proto Labs
Jul 6, 2026
Reiterated: Buy
Price Target: $91
Current: $94.37
Upside: -3.57%
Bio-Techne
Jun 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $72.40
Upside: -
Integer Holdings
Feb 20, 2026
Upgraded: Buy
Price Target: $140 → $95
Current: $126.42
Upside: -24.85%
Halozyme Therapeutics
Feb 19, 2026
Reiterated: Buy
Price Target: $90
Current: $106.94
Upside: -15.84%
Codexis
Nov 14, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.36
Upside: -
OmniAb
Nov 6, 2025
Reiterated: Buy
Price Target: $6 → $4
Current: $4.99
Upside: -19.84%
Oct 31, 2025
Reiterated: Buy
Price Target: $38
Current: $3.21
Upside: +1,068.22%
Aug 13, 2025
Reiterated: Hold
Price Target: n/a
Current: $13.91
Upside: n/a
Aug 12, 2025
Reiterated: Buy
Price Target: $5
Current: $3.67
Upside: n/a
Aug 8, 2025
Reiterated: Buy
Price Target: $12
Current: $6.37
Upside: n/a
Jul 31, 2025
Reiterated: Buy
Price Target: $3
Current: $1.33
Upside: n/a
Feb 3, 2025
Downgraded: Hold
Price Target: $4
Current: $3.49
Upside: n/a
Oct 26, 2023
Reiterated: Hold
Price Target: n/a
Current: $652.51
Upside: n/a
Oct 25, 2023
Reiterated: Hold
Price Target: n/a
Current: $211.76
Upside: n/a
Sep 15, 2023
Reiterated: Hold
Price Target: n/a
Current: $4.88
Upside: n/a
Apr 4, 2023
Reiterated: Buy
Price Target: $9 → $80
Current: $1.62
Upside: n/a
Feb 24, 2021
Reiterated: Buy
Price Target: $9
Current: $2.07
Upside: n/a
Jan 24, 2020
Rated: Hold
Price Target: n/a
Current: $2.09
Upside: n/a
Jan 9, 2019
Initiated Coverage: Buy
Price Target: $11
Current: $0.45
Upside: n/a
Aug 28, 2018
Initiated Coverage: Buy
Price Target: $46
Current: $0.749
Upside: n/a
Jan 29, 2018
Initiated Coverage: Buy
Price Target: $2.4
Current: $2.04
Upside: n/a
Nov 7, 2013
Initiated Coverage: Buy
Price Target: $5.25
Current: $0.8213
Upside: n/a
Mar 12, 2013
Reiterated: Buy
Price Target: $6
Current: $8.33
Upside: n/a